2016•Gynecologic OncologyRequires access

Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy

Isabelle Ray‐Coquard, E. Rizzo, Jean‐Yves Blay, Paolo G. Casali, Ian Judson, Annette Hansen, Lars H. Lindner, Angelo Paolo Dei Tos, Hans Gelderblom, Sandrine Marréaud, Saskia Litière, Piotr Rutkowski, Peter Hohenberger, Alessandro Gronchi, Winette T.A. van der Graaf

Open publisher page 15 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ifosfamide, Medicine, Chemotherapy, Sarcoma, Soft tissue sarcoma, Doxorubicin, Cyclophosphamide, Soft tissue

Back to paper search Browse research topics Original source

Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy — Research Paper | ScholarLens